CA2624049C - Herbal composition for inflammatory disorders - Google Patents

Herbal composition for inflammatory disorders Download PDF

Info

Publication number
CA2624049C
CA2624049C CA2624049A CA2624049A CA2624049C CA 2624049 C CA2624049 C CA 2624049C CA 2624049 A CA2624049 A CA 2624049A CA 2624049 A CA2624049 A CA 2624049A CA 2624049 C CA2624049 C CA 2624049C
Authority
CA
Canada
Prior art keywords
extract
compound
inflammatory
sphaeranthus indicus
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2624049A
Other languages
English (en)
French (fr)
Other versions
CA2624049A1 (en
Inventor
Vijay Chauhan
Ashish Suthar
Dhananjay Sapre
Swati Bal-Tembe
Ashok Kumar Gangopadhyay
Asha Kulkarni-Almeida
Sapna Hasit Parikh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Piramal Enterprises Ltd
Original Assignee
Piramal Enterprises Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Piramal Enterprises Ltd filed Critical Piramal Enterprises Ltd
Publication of CA2624049A1 publication Critical patent/CA2624049A1/en
Application granted granted Critical
Publication of CA2624049C publication Critical patent/CA2624049C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
CA2624049A 2005-09-30 2006-09-28 Herbal composition for inflammatory disorders Active CA2624049C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN1226MU2005 2005-09-30
IN1226/MUM/2005 2005-09-30
US73644305P 2005-11-14 2005-11-14
US60/736,443 2005-11-14
PCT/IB2006/053540 WO2007036900A2 (en) 2005-09-30 2006-09-28 Herbal composition for inflammatory disorders

Publications (2)

Publication Number Publication Date
CA2624049A1 CA2624049A1 (en) 2007-04-05
CA2624049C true CA2624049C (en) 2016-01-12

Family

ID=37900158

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2624049A Active CA2624049C (en) 2005-09-30 2006-09-28 Herbal composition for inflammatory disorders

Country Status (10)

Country Link
US (2) US7635494B2 (https=)
EP (1) EP1931366B1 (https=)
JP (1) JP5331962B2 (https=)
AU (1) AU2006296197B2 (https=)
CA (1) CA2624049C (https=)
EA (1) EA014070B1 (https=)
GE (1) GEP20115332B (https=)
MA (1) MA29890B1 (https=)
PL (1) PL1931366T3 (https=)
WO (1) WO2007036900A2 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009016565A1 (en) * 2007-07-27 2009-02-05 Piramal Life Sciences Limited Tricyclic compounds for the treatment of inflammatory disorders
US8383166B2 (en) * 2007-12-03 2013-02-26 Sequent Scientific Limited Stable hydrophobic topical herbal formulationn
CA2751227C (en) 2009-02-02 2021-10-26 Laila Nutraceuticals Composition from sphaeranthus indicus and garcinia mangostana for the control of metabolic syndrome
WO2012014216A1 (en) * 2010-07-28 2012-02-02 Laila Nutraceuticals 7-hydroxyfrullanolide and its analogs for prevention, control and treatment of metabolic disorders
US10105347B2 (en) 2009-02-02 2018-10-23 Laila Nutraceuticals Sphaeranthus indicus derived ingredients and their compositions for enhancing physical performance and energy levels
WO2011033524A2 (en) 2009-08-04 2011-03-24 Laila Nutraceuticals Agents from ficus hispida for the amelioration of metabolic syndrome and related diseases
WO2011083397A1 (en) * 2010-01-05 2011-07-14 Himalaya Global Holdings Limited Herbal composition for skin disorders
PH12013500451A1 (en) * 2010-09-11 2013-05-20 Laila Nutraceuticals Sphaeranthus indicus derived ingredients and their compositions for enhancing physical performance and energy levels
US8263579B2 (en) * 2011-01-24 2012-09-11 Piramal Healthcare Limited Anti-inflammatory compounds
WO2014064609A2 (en) * 2012-10-23 2014-05-01 Piramal Enterprises Limited HERBAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF TNF-α MEDIATED DISEASES
US10792305B2 (en) 2015-06-23 2020-10-06 Nobilis Therapeutics, Inc. Therapeutic immune modulation using noble gas compositions
BR112018073483B1 (pt) * 2016-05-21 2022-08-23 Laila Impex Suplementos e composições dietéticas para a melhoria do desempenho físico e dos níveis de energia

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646687A (en) * 1994-12-29 1997-07-08 Lucent Technologies Inc. Temporally-pipelined predictive encoder/decoder circuit and method
US6204523B1 (en) * 1998-11-06 2001-03-20 Lumileds Lighting, U.S., Llc High stability optical encapsulation and packaging for light-emitting diodes in the green, blue, and near UV range
US6686676B2 (en) * 2001-04-30 2004-02-03 General Electric Company UV reflectors and UV-based light sources having reduced UV radiation leakage incorporating the same
US6989412B2 (en) * 2001-06-06 2006-01-24 Henkel Corporation Epoxy molding compounds containing phosphor and process for preparing such compositions
US6841647B2 (en) * 2001-11-06 2005-01-11 National Starch And Chemical Investment Holding Corporation Fluid resistant silicone encapsulant
US7160972B2 (en) * 2003-02-19 2007-01-09 Nusil Technology Llc Optically clear high temperature resistant silicone polymers of high refractive index
US7261441B2 (en) * 2004-02-27 2007-08-28 Avago Technologies Ecbu Ip (Singapore) Pte. Ltd. LED device and method for directing LED light
WO2006016228A2 (en) * 2004-08-02 2006-02-16 Prashanth Kumar V Cytotoxic peptide alkaloid and pharmaceutical compositions for the treatment of neoplastic diseases
US7229934B2 (en) * 2004-10-18 2007-06-12 International Business Machines Corporation Porous organosilicates with improved mechanical properties

Also Published As

Publication number Publication date
EP1931366A2 (en) 2008-06-18
PL1931366T3 (pl) 2013-11-29
EA014070B1 (ru) 2010-08-30
WO2007036900A3 (en) 2007-08-02
CA2624049A1 (en) 2007-04-05
US7635494B2 (en) 2009-12-22
JP2009510051A (ja) 2009-03-12
AU2006296197A2 (en) 2008-06-05
AU2006296197B2 (en) 2012-08-09
HK1112418A1 (en) 2008-09-05
US20090269427A1 (en) 2009-10-29
MA29890B1 (fr) 2008-10-03
EP1931366B1 (en) 2013-05-29
US20080254157A1 (en) 2008-10-16
WO2007036900A2 (en) 2007-04-05
GEP20115332B (en) 2011-11-25
EA200800850A1 (ru) 2008-10-30
AU2006296197A1 (en) 2007-04-05
US8206756B2 (en) 2012-06-26
JP5331962B2 (ja) 2013-10-30

Similar Documents

Publication Publication Date Title
US7635494B2 (en) Herbal composition for inflammatory disorders
RU2668135C1 (ru) Фармацевтическая композиция для лечения и предотвращения дегенеративных неврологических нарушений, которая содержит, в качестве активного ингредиента, смешанный экстракт коры корня пиона полукустарникового, корня дудника даурского и корня володушки или его фракцию
KR101285234B1 (ko) 백미 추출물을 포함하는 관절염 예방 및 치료용 조성물
RU2438692C2 (ru) Растительный экстракт и его терапевтическое применение
KR20170066585A (ko) 골관절염에 대한 상승적인 조성물
US8945633B2 (en) Pharmaceutical composition for preventing and treating inflammatory diseases containing an ethyl acetate fraction of dried extract of Trachelospermi caulis as an active ingredient, and method for producing the fraction
CN113773409B (zh) 倒心盾翅藤多糖及其用途
EP1414475B1 (en) An herbal composition for the treatment and remedy of bronchial respiratory difficulties
CN101304756B (zh) 用于炎性病症的草药组合物
JP2000503686A (ja) 黄栢皮とオミナエシ植物の混合抽出物を含有するｃ型肝炎治療用製薬組成物
US7862837B2 (en) Herbal composition
US6413553B1 (en) Herbal formulation of a combination of Piper betel and Murrya koenigii extracts for blocking 5 lipoxygenase activity
Aiyalu et al. Formulation and Evaluation of Novel Herbal Aerosol for Arthritis
HK1112418B (en) Herbal composition for inflammatory disorders
MX2008004291A (es) Composicion herbaria para trastornos inflamatorios
Dafar et al. A Review on Phytochemical and Pharmacological Study of Herbal Medicinal Plant: Abrus precatorious
KR20110090283A (ko) 식물 추출물을 포함하는 치주질환용 조성물
Gopalakrishnan et al. Antihepatotoxic acticity of Coccinia indica
Onwuzuligbo et al. Evaluation of anti-inflammatory activities of ethanolic extract and solvent fractions of Cleistopholis staudtii leaves
Vieira et al. Gastro-protective effects of isobrucein B, a quassinoid isolated from Picrolemma sprucei
KR100825869B1 (ko) 항천식 활성을 가지는 신선초 추출물
Gbogbo et al. HAEMATOLOGICAL, BIOCHEMICAL AND HISTOLOGICAL TOXICITY OF THE ETHANOLIC EXTRACT OF MASSULARIA ACUMINATA (G. DON) BULLOCK EX HOLY.(RUBIACEAE) STEMS IN RAT
Henri et al. Effects of Cola anomala (K. Schum.) water/ethanol pods extract on the inflammation and intestinal secretion in lipopolysaccharide-induced diarrhea.
CN103330722A (zh) 一种长白山红蚂蚁提取物的制备方法
KR20160087371A (ko) 정공등복합방 추출물을 포함하는 항산화 및 항염증용 약학적 조성물

Legal Events

Date Code Title Description
EEER Examination request
MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 18TH ANNIV.) - STANDARD

Year of fee payment: 18

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20240926

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20240926